Global Intelligent Asthma Monitoring Devices Market Overview:
Intelligent Asthma Monitoring Device is used to monitor asthma to avoid attacks and related morbidity. Asthma management requires patients' active commitment to engage in self-monitoring routines. The rise in air pollution is fueling the global market for intelligent asthma monitoring devices. Increased asthma susceptibility due to indoor air pollution, as well as an alarming rise in the global prevalence of COPD and asthma, are projected to drive market growth.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Growth in the Number of Phone-Based Apps and Smart Inhalers
Market Growth Drivers:
Rise in Allergic Reactions toward Pollen, Dust, and Other Allergens and Increasing Prevalence Of COPD & Asthma
Challenges:
Lack of Awareness
Restraints:
Accuracy and Reliability of the Device
Opportunities:
High Demand from Emerging Economies and Advancements in the Intelligent Asthma Monitoring Devices
Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Adherium Limited (New Zealand), AstraZeneca (United Kingdom), Cohero Health (United States), GlaxoSmithKline plc (United Kingdom), Health Care Originals (United States), Koninklijke Philips N.V (Netherlands), Propeller Health (United States), Teva Pharmaceutical Industries Ltd. (Israel), Vectura Group plc (United Kingdom) and Volansys Technologies (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Intelligent Asthma Monitoring Devices market by 2028.
Latest Market Insights:
On MAY 24 2019, Apple buys Tueo Health, which was working on a solution to help parents monitor asthma symptoms in children using a mobile app and commercial breathing sensors.
What Can be Explored with the Intelligent Asthma Monitoring Devices Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Intelligent Asthma Monitoring Devices Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Intelligent Asthma Monitoring Devices
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Intelligent Asthma Monitoring Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Intelligent Asthma Monitoring Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Manufacturers of Intelligent Asthma Monitoring Device, Distributors and Suppliers of Intelligent Asthma Monitoring Device, Public and Private Physicians, Clinical Laboratories, Healthcare Institutions and Research Firms.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.